Page 308 - Read Online
P. 308

Page 8 of 9                                                Martini et al. Hepatoma Res 2018;4:28  I  http://dx.doi.org/10.20517/2394-5079.2018.50

               24.  Ciscato F, Sciacovelli M, Villano G, Turato C, Bernardi P, Rasola A, Pontisso P. SERPINB3 protects from oxidative damage by
                   chemotherapeutics through inhibition of mitochondrial respiratory complex I. Oncotarget 2014;5:2418-27.
               25.  Quarta S, Vidalino L, Turato C, Ruvoletto M, Calabrese F, Valente M, Cannito S, Fassina G, Parola M, Gatta A, Pontisso P. SERPINB3
                   induces epithelial-mesenchymal transition. J Pathol 2010;221:343-56.
               26.  Villano G, Quarta S, Ruvoletto MG, Turato C, Vidalino L, Biasiolo A, Tono N, Lunardi F, Calabrese F, Dall’olmo L, Dedja A, Fassina
                   G, Gatta A, Pontisso P. Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. Int J Mol
                   Med 2010;25:137-43.
               27.  Turato C, Cannito S, Simonato D, Villano G, Morello E, Terrin L, Quarta S, Biasiolo A, Ruvoletto M, Martini A, Fasolato S, Zanus G,
                   Cillo U, Gatta A, Parola M, Pontisso P. SerpinB3 and Yap interplay increases Myc oncogenic activity. Sci Rep 2015;5:17701.
               28.  Catanzaro JM, Sheshadri N, Pan JA, Sun Y, Shi C, Li J, Powers RS, Crawford HC, Zong WX. Oncogenic Ras induces inflammatory
                   cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4. Nat Commun 2014;5:3729.
               29.  Fasolato S, Trevellin E, Ruvoletto M, Granzotto M, Zanus G, Boscaro E, Babetto E, Terrin L, Battocchio MA, Ciscato F, Turato
                   C, Quarta S, Cillo U, Pontisso P, Vettor R. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in
                   hepatocellular carcinoma. Life Sci 2018;200:134-41.
               30.  Shirakawa J, Fujii H, Ohnuma K, Sato K, Ito Y, Kaji M, Sasaki H, Nagashima Y, Amo K, Aoki K, Morimoto C, Takeda E, Terauchi Y. Diet-
                   induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice. Diabetes 2011;60:1246-57.
               31.  Akarte AS, Srinivasan BP, Gandhi S, Sole S. Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene
                   expressions responsible for insulin secretion in streptozotocin induced diabetic rats. Eur J Pharm Sci 2012;47:456-63.
               32.  Blaslov K, Bulum T, Zibar K, Duvnjak L. Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease.
                   World J Gastroenterol 2014;20:7356-65.
               33.  Villano G, Ruvoletto M, Ceolotto G, Quarta S, Calabrese F, Turato C, Tono N, Crescenzi M, Biasiolo A, Cattelan A, Merkel C, Avogaro
                   A, Gatta A, Pontisso P. SERPINB3 is associated with longer survival in transgenic mice. Sci Rep 2013;3:3056.
               34.  Martini A, Fattovich G, Guido M, Bugianesi E, Biasiolo A, Ieluzzi D, Gallotta A, Fassina G, Merkel C, Gatta A, Negro F, Pontisso P.
                   HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH
                   in HCV-infected patients. J Viral Hepat. 2015;22:800-8.
               35.  Guido M, Roskams T, Pontisso P, Fassan M, Thung SN, Giacomelli L, Sergio A, Farinati F, Cillo U, Rugge M. Squamous cell
                   carcinoma antigen in human liver carcinogenesis. J Clin Pathol 2008;61:445-7.
               36.  Pontisso P, Calabrese F, Benvegnu L, Lise M, Belluco C, Ruvoletto MG, Marino M, Valente M, Nitti D, Gatta A, Fassina G.
                   Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 2004;90:833-7.
               37.  Trerotoli P, Fransvea E, Angelotti U, Antonaci G, Lupo L, Mazzocca A, Mangia A, Antonaci S, Giannelli G. Tissue expression of
                   Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC. Mol Cancer 2009;8:29.
               38.  Turato C, Buendia MA, Fabre M, Redon MJ, Branchereau S, Quarta S, Ruvoletto M, Perilongo G, Grotzer MA, Gatta A, Pontisso P.
                   Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour? Eur J Cancer 2012;48:1219-26.
               39.  Villano G, Turato C, Quarta S, Ruvoletto M, Ciscato F, Terrin L, Semeraro R, Paternostro C, Parola M, Alvaro D, Bernardi P, Gatta A,
                   Pontisso P. Hepatic progenitor cells express SerpinB3. BMC Cell Biol 2014;15:5.
               40.  Turato C, Calabrese F, Biasiolo A, Quarta S, Ruvoletto M, Tono N, Paccagnella D, Fassina G, Merkel C, Harrison TJ, Gatta A, Pontisso P.
                   SERPINB3 modulates TGF-beta expression in chronic liver disease. Lab Invest 2010;90:1016-23.
               41.  Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM. Role of the microenvironment in the pathogenesis and treatment of
                   hepatocellular carcinoma. Gastroenterology 2013;144:512-27.
               42.  Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72.
               43.  Novo E, Villano G, Turato C, Cannito S, Paternostro C, Busletta C, Biasiolo A, Quarta S, Morello E, Bocca C, Miglietta A, David E,
                   Sutti S, Plebani M, Albano E, Parola M, Pontisso P. SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells. Sci
                   Rep 2017;7:3420-3.
               44.  Ringelhan M, Pfister D, O’Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol
                   2018;19:222-32.
               45.  Roth GS, Decaens T. Liver immunotolerance and hepatocellular carcinoma: patho-physiological mechanisms and therapeutic
                   perspectives. Eur J Cancer 2017;87:101-12.
               46.  Carambia A, Freund B, Schwinge D, Heine M, Laschtowitz A, Huber S, Wraith DC, Korn T, Schramm C, Lohse AW, Heeren J, Herkel J.
                   TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells. J Hepatol 2014;61:594-9.
               47.  Suminami Y, Nagashima S, Murakami A, Nawata S, Gondo T, Hirakawa H, Numa F, Silverman GA, Kato H. Suppression of a
                   squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural
                   killer cells. Cancer Res 2001;61:1776-80.
               48.  Lunardi F, Villano G, Perissinotto E, Agostini C, Rea F, Gnoato M, Bradaschia A, Valente M, Pontisso P, Calabrese F. Overexpression
                   of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. Lab Invest 2011;91:945-54.
               49.  Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, Solinas A, Mura D, Brouwer JT, Thomas H, Njapoum
                   C, Casarin C, Bonetti P, Fuschi P, Basho J, Tocco A, Bhalla A, Galassini R, Noventa F, Schalm SW, Realdi G. Morbidity and mortality
                   in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-72.
               50.  Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G. Squamous cell
                   carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Cancer 2005;103:2558-65.
               51.  Rubin B. Natural immunity has significant impact on immune responses against cancer. Scand J Immunol 2009;69:275-90.
   303   304   305   306   307   308   309   310   311   312   313